Blood test after delivery could prevent deadly preeclampsia

NCT ID NCT07185204

Recruiting now Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study in Nepal tests whether a blood test before delivery can predict which women will develop dangerous high blood pressure after giving birth. Women at high risk will receive a care bundle including remote blood pressure monitoring, education, and medication to manage their condition early. The goal is to see if this approach is feasible and reduces the need for emergency care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nifedipine ER (blood pressure medication)
What this could lead to: If successful, this could lead to a simple, scalable way to catch and treat postpartum preeclampsia early, reducing serious complications.
What could go wrong: This is a very small pilot study (60 people) focused on feasibility, not proof of effectiveness. The results may not apply to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder preeclampsia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTPARTUM PREECLAMPSIA

Contacts and locations

Locations

Dhulikhel Hospital
RECRUITING

Dhulikhel, Nepal
Medical College of Wisconsin
ACTIVE_NOT_RECRUITING

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.